These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neurological involvement in antiphospholipid antibodies syndrome (APS). Amoroso A; Mitterhofer AP; Ferri GM; Galluzzo S; Vadacca M; Afeltra A Eur Rev Med Pharmacol Sci; 1999; 3(5):205-9. PubMed ID: 11075618 [TBL] [Abstract][Full Text] [Related]
4. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E Lupus; 2007; 16(1):39-45. PubMed ID: 17283584 [TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid syndrome - an update. Linnemann B Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764 [TBL] [Abstract][Full Text] [Related]
6. [Neurological aspects in antiphospholipid syndrome]. Kitagawa Y Rinsho Shinkeigaku; 2003 Nov; 43(11):744-7. PubMed ID: 15152454 [TBL] [Abstract][Full Text] [Related]
7. Neurologic symptoms as a feature of the antiphospholipid syndrome. Miesbach W Semin Thromb Hemost; 2008 Apr; 34(3):286-9. PubMed ID: 18720309 [TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome? Berkun Y; Simchen MJ; Strauss T; Menashcu S; Padeh S; Kenet G Lupus; 2014 Sep; 23(10):986-93. PubMed ID: 24729280 [TBL] [Abstract][Full Text] [Related]
9. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies. Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581 [TBL] [Abstract][Full Text] [Related]
10. International survey on the management of patients with SLE. II. The results of a questionnaire regarding neuropsychiatric manifestations. Tincani A; Brey R; Balestrieri G; Vitali C; Doria A; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S Clin Exp Rheumatol; 1996; 14 Suppl 16():S23-9. PubMed ID: 9049450 [TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of antiphospholipid antibody in pediatric patients and review of literature]. Xiao HJ; Yang JY; Gao TJ; Huang JP; Yao Y; Zhang Y Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):571-3. PubMed ID: 15347440 [TBL] [Abstract][Full Text] [Related]
12. Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome. Stojanovich L; Kontic M; Smiljanic D; Djokovic A; Stamenkovic B; Marisavljevic D Clin Exp Rheumatol; 2013; 31(5):756-60. PubMed ID: 23899875 [TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases. Tănăsescu R; Nicolau A; Caraiola S; Ticmeanu M; Cojocaru IM; Frăsineanu A; Ionescu R; Hristea A; Ene A; Anghel D; Tănăsescu R; Băicuş C Rom J Intern Med; 2007; 45(4):355-63. PubMed ID: 18767411 [TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus. İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of antiphospholipid antibodies in patients with neurological symptoms. Miesbach W; Gilzinger A; Gökpinar B; Claus D; Scharrer I Clin Neurol Neurosurg; 2006 Feb; 108(2):135-42. PubMed ID: 16412834 [TBL] [Abstract][Full Text] [Related]
16. Cerebral manifestations in the antiphospholipid (Hughes) syndrome. Sanna G; D'Cruz D; Cuadrado MJ Rheum Dis Clin North Am; 2006 Aug; 32(3):465-90. PubMed ID: 16880079 [TBL] [Abstract][Full Text] [Related]